Aberrant serum hyaluronan and hyaluronidase levels in scleroderma

British Journal of Dermatology

Volumn 150, Issue 3, 2004, Pages 469-476

  Neudecker, B A ^a   Stern, R ^a   Connolly, M K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Extracellular matrix; Hyal 1; Hyaluronan; Hyaluronidase; Scleroderma

Indexed keywords

COLLAGEN; HYALURONIC ACID; HYALURONIDASE; METHOTREXATE; PENICILLAMINE; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EARLY DIAGNOSIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN FAMILY; SCAR; SCLERODERMA; SKIN FIBROSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; WOUND HEALING;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; TIME FACTORS;

EID: 1842558959     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2004.05805.x     Document Type: Article

References (75)

1. LeRoy EC, Black C, Fleishmayer R et al. Scleroderma (systemic sclerosis). Classifications, subsets, and pathogenesis. J Rheumatol 1988; 15: 202-5.
2. Sapadin AN, Esser AC, Fleischmajer R. Immunopathogenesis of scleroderma - evolving concepts. Mt Sinai J Med 2000; 68: 233-42.
3. Bashey RI, Millan A, Jimenez SA. Increased biosynthesis of glycosaminoglycans by scleroderma fibroblasts in culture. Arthritis Rheum 1984; 27: 1040-5.
4. Fleischmajer R, Perlish JS, Krieg T, Timpl R. Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 1981; 76: 400-3.
5. Shi-wen X, Pennington D, Holmes A et al. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res 2000; 259: 213-24.
6. Sugiyama Y, Shimada A, Sayo T et al. Putative hyaluronan synthase mRNAs are expressed in mouse skin and TGF-beta up-regulates their expression in cultured human skin cells. J Invest Dermatol 1998; 110: 116-21.
7. Ellis IR, Schor SL. Differential motogenic and biosynthetic response of fetal and adult skin fibroblasts to TGF-beta isoforms. Cytokine 1998; 10: 281-9.
8. Papakonstantinou E, Karakiulakis G, Roth M, Block LH. Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells. Proc Natl Acad Sci USA 1995; 92: 9881-5.
9. Pullen M, Thomas K, Wu H, Nambi P. Stimulation of hyaluronan synthetase by platelet-derived growth factor bb in human prostate smooth muscle cells. Pharmacology 2001; 62: 103-6.
10. Toole BP. Proteoglycans and hyaluronan in morphogenesis and differentiation. In: Cell Biology of the Extracellular Matrix (Hay ED, ed.), 2nd edn. New York: Plenum Press, 1991: 259-94.
11. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992; 6: 2397-404.
12. Lee JY, Spicer AP. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol 2000; 12: 581-6.
13. Delpech B, Girard N, Bertrand P et al. Hyaluronan: fundamental principles and applications in cancer. J Intern Med 1997; 242: 41-8.
14. Reed RK, Lilja K, Laurent TC. Hyaluronan in the rat with special reference to the skin. Acta Physiol Scand 1988; 134: 405-11.
15. Laurent UB, Dahl LB, Reed RK. Catabolism of hyaluronan in rabbit skin takes place locally, in lymph nodes and liver. Exp Physiol 1991; 76: 695-703.
16. Engstrom-Laurent A, Hellstrom S. The role of liver and kidneys in the removal of circulating hyaluronan. An experimental study in the rat. Connect Tissue Res 1990; 24: 219-24.
17. Reed RK, Laurent UB, Fraser JR, Laurent TC. Removal rate of [3H]hyaluronan injected subcutaneously in rabbits. Am J Physiol 1990; 259: H532-5.
18. Engstrom-Laurent A, Feltelius N, Hallgren R, Wasteson A. Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis 1985; 44: 614-20.
19. Horslev-Petersen K, Ammitzboll T, Engstrom-Laurent A et al. Serum and urinary aminoterminal type in procollagen peptide in progressive systemic sclerosis: relationship to sclerodermic involvement, serum hyaluronan and urinary collagen metabolites. J Rheumatol 1988; 15: 460-7.
20. Gotting C, Kuhn J, Sollberg S et al. Elevated serum xylosyltransferase activity correlates with a high level of hyaluronate in patients with systemic sclerosis. Acta Derm Venereol (Stockh) 2000; 80: 60-1.
21. Freitas JP, Filipe P, Emerit I et al. Hyaluronic acid in progressive systemic sclerosis. Dermatology 1996; 192: 46-9.
22. Scheja A, Akesson A, Horslev-Petersen K. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis. Scand J Rheumatol 1992; 21: 5-9.
23. Juhlin L, Tengblad A, Ortonne JP, Lacour JPH. Hyaluronate in suction blisters from patients with scleroderma and various skin disorders. Acta Derm Venereol (Stockh) 1986; 66: 409-13.
24. Sondergaard K, Heickendorff L, Risteli L et al. Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Br J Dermatol 1997; 136: 47-53.
25. Levesque H, Delpech B, Le Loet X, Deshayes P. Serum hyaluronate in rheumatoid arthritis: study by affino-immunoenzymatic assay. Br J Rheumatol 1988; 27: 445-9.
26. Elkayam O, Yaron I, Shirazi I et al. Serum levels of hyaluronic acid in patients with psoriatic arthritis. Clin Rheumatol 2000; 19: 455-7.
27. Kubo M, Kikuchi K, Yazawa N et al. Increased serum concentration of hyaluronate in dermatomyositis patients. Arch Dermatol Res 1998; 290: 579-81.
28. Dhawan A, Trivedi P, Cheeseman P et al. Serum hyaluronic acid as an early prognostic marker in biliary atresia. J Pediatr Surg 2001; 36: 443-6.
29. Schon MR, Eisenberg JU, Lemmens HP et al. The correlation of serum hyaluronan of liver donors with posttransplant liver function. Transpl Int 1994; 7 (Suppl. 1): S128-33.
30. Stickel F, Urbaschek R, Schuppan D et al. Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease. Dig Dis Sci 2001; 46: 2025-32.
31. Manley G, Warren C. Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol 1987; 40: 626-30.
32. Wilkinson CR, Bower LM, Warren C. The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm. Clin Chim Acta 1996; 256: 165-73.
33. Delpech B, Chevallier B, Reinhardt N et al. Serum hyaluronan in breast cancer. Int J Cancer 1990; 46: 388-90.
34. Hasselbalch H, Hovgaard D, Nissen N, Junker P. Serum hyaluronan is increased in malignant lymphoma. Am J Hematol 1995; 50: 231-3.
35. Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 1986; 119: 219-34.
36. Longaker MT, Chiu ES, Adzick NS et al. Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg 1991; 213: 292-6.
37. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
38. Kahaleh MB, Sultany GL, Smith EA et al. A modified scleroderma skin scoring method. Clin Exp Rheumatol 1986; 4: 367-9.
39. Fosang AJ, Hey NJ, Carney SL, Hardingham TE. An ELISA plate-based assay for hyaluronan using biotinylated proteoglycan G1 domain (HA-binding region). Matrix 1990; 10: 306-13.
40. Tengblad A. Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding properties from cartilage. Biochim Biophys Acta 1979; 578: 281-9.
41. Frost GI, Stern R. A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Anal Biochem 1997; 251: 263-9.
42. Tolksdorf S, McCready MH, McCullagh DR, Schwenk E. The turbidometric assay of hyaluronidase. J Lab Clin Med 1949; 34: 74-9.
43. Afify AM, Stern M, Guntenhoner M, Stern R. Purification and characterization of human serum hyaluronidase. Arch Biochem Biophys 1993; 305: 434-41.
44. Frost GI, Csoka TB, Wong T, Stern R. Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 1997; 236: 10-15.
45. Granger HJ, Laine GA, Barnes GE, Lewis RE. Dynamics and control of transmicrovascular fluid exchange. In: Edema (Staub NC, Taylor AE, eds). New York: Raven Press, 1984: 189-228.
46. Kreil G. Hyaluronidases - a group of neglected enzymes. Protein Sci. 1995; 4: 1666-9.
47. Csoka AB, Frost GI, Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 2001; 20: 499-508.
48. Csoka AB, Scherer SW, Stern R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics 1999; 60: 356-61.
49. Csoka TB, Frost GI, Wong T, Stern R. Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett 1997; 417: 307-10.
50. Stair-Nawy S, Csoka AB, Stern R. Hyaluronidase expression in human skin fibroblasts. Biochem Biophys Res Commun 1999; 266: 268-73.
51. Arbogast B, Hopwood JJ, Dorfman A. Absence of hyaluronidase in cultured human skin fibroblasts. Biochem Biophys Res Commun 1975; 67: 376-82.
52. Klein U, von Figura K. Characterization of dermatan sulfate in mucopolysaccharidosis VI. Evidence for the absence of hyaluronidase-like enzymes in human skin fibroblasts. Biochim Biophys Acta 1980; 630: 10-14.
53. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985; 228: 1324-6.
54. Feinberg RN, Beebe DC. Hyaluronate in vasculogenesis. Science 1983; 220: 1177-9.
55. Lepperdinger G, Strobl B, Kreil G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem 1998; 273: 22466-70.
56. Lepperdinger G, Mullegger J, Kreil G. Hyal2 - less active, but more versatile? Matrix Biol 2001; 20: 509-14.
57. Noble PW, McKee CM, Cowman M, Shin HS. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J Exp Med 1996; 183: 2373-8.
58. McKee CM, Penno MB, Cowman M et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996; 98: 2403-13.
59. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002; 21: 25-9.
60. Termeer CC, Hennies J, Voith U et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000; 165: 1863-70.
61. West DC, Shaw DM, Lorenz P et al. Fibrotic healing of adult and late gestation fetal wounds correlates with increased hyaluronidase activity and removal of hyaluronan. Int J Biochem Cell Biol 1997; 29: 201-10.
62. Li Y, Rahmanian M, Widstrom C et al. Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types I and III collagen gene expression. Am J Respir Cell Mol Biol 2000; 23: 411-18.
63. Liu B, Connolly MK. The pathogenesis of cutaneous fibrosis. Semin Cutan Med Surg 1998; 17: 3-11.
64. Locci P, Marinucci L, Lilli C et al. Transforming growth factor beta 1-hyaluronic acid interaction. Cell Tissue Res 1995; 281: 317-24.
65. Levesque H, Baudot N, Delpech B et al. Clinical correlations and prognosis based on hyaluronic acid serum levels in patients with progressive systemic sclerosis. Br J Dermatol 1991; 124: 423-8.
66. De Salegui M, Plonska H, Pigman W. A comparison of serum and testicular hyaluronidase. Arch Biochem Biophys 1967; 121: 548-54.
67. Cherr GN, Yudin AI, Overstreet JW. The dual functions of GPI-anchored PH-20: hyaluronidase and intracellular signaling. Matrix Biol 2001; 20: 515-25.
68. Duran-Reynals F. Exaltation de l'activité du virus vaccinal par les extraits de certains organes. Compt Rend Soc Biol 1928; 99: 6-7.
69. Duran-Reynals F, Suner Pi J. Exaltation de l'activité du staphylocoque par les extraits testiculaires. Compt Rend Soc Biol 1929; 99: 1908-11.
70. Cherr GN, Meyers SA, Yudin AI et al. The PH-20 protein in cynomolgus macaque spermatozoa: identification of two different forms exhibiting hyaluronidase activity. Dev Biol 1996; 175: 142-53.
71. Meyer MF, Kreil G, Aschauer H. The soluble hyaluronidase from bull testes is a fragment of the membrane-bound PH-20 enzyme. FEBS Lett 1997; 413: 385-8.
72. Popkin RJ. The use of hyaluronidase by iontophoresis in the treatment of generalized scleroderma. J Invest Dermatol 1950; 23: 97-102.
73. Wozniak KD, Braun W. [Treatment with hyaluronidase in dermatology]. Z Arztl Fortbild (Jena) 1975; 69: 1109-10.
74. Fischer M, Bormann G, Wohlrab J, Marsch WC. Radiation-induced morphea. Hautarzt 1999; 50: 507-10.
75. Mahrle G, Herrmann WP, Steigleder GK. [Hyaluronidase therapy of progressive scleroderma]. Hautarzt 1972; 23: 305-7.